NEW YORK (GenomeWeb News) – Response Genetics today said it has signed agreements with four payors to provide access to the molecular diagnostic firm's tests.

The deals are with America's Choice Provider Network, FedMed, Galaxy Health Network, and Prime Health Services, and increases the number of people in the US who now have access to Response's tests by 54 million, the company said. It added that in 2013, it has entered into a total of six PPO network contracts providing access to its tests to more than 135 million Americans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.